Article(id=1322631264893513790, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631228000424183, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.18.008, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1778774400000, receivedDateStr=2026-05-15, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793269466851, onlineDateStr=2026-10-29, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793269466851, onlineIssueDateStr=2026-10-29, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793269466851, creator=13701087609, updateTime=1793269466851, updator=13701087609, issue=Issue{id=1322631228000424183, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='18', pageStart='7073', pageEnd='7500', issueExtLink='null', onlineDate='null', pubDate='1790524800000', pubDateStr='2026-09-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793269458054, creator='13701087609', updateTime=1793269548245, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322631606339228314, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631228000424183, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322631606339228315, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1322631228000424183, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=7162, endPage=7177, ext={EN=ArticleExt(id=1322631265421996096, articleId=1322631264893513790, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Mechanism of Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair alleviates hepatic fibrosis through inhibition of ERVs/RLRs/IFN-I signaling pathway, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To investigate the mechanism by which Huangqi (Astragali Radix)-Danshen (Salviae Miltiorrhizae Radix et Rhizoma) herb pair (HQ-DS) in treating hepatic fibrosis (HF) via regulating the endogenous retroviruses (ERVs)/retinoic acid-inducible gene I-like receptors (RLRs)/type I interferon (IFN-I) signaling pathway. Methods The components of HQ-DS extract and drug-containing serum were analyzed and identified using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). A total of 48 male C57BL/6J mice were randomly divided into control group, model group, HQ-DS low-, medium-, high-dose (4.55, 9.10, 18.20 g/kg) groups and silymarin (100 mg/kg) group, with eight mice in each group. A mouse model of HF was established using carbon tetrachloride (CCl4), and after drug intervention, liver function related indicators in serum were detected. The pathological changes of liver tissue through hematoxylin eosin (HE) staining, Masson and Sirius red staining were observed. Flow cytometry was used to detect macrophage infiltration in liver tissue. Western blotting was used to detect the expressions of fibrosis related proteins in liver tissue. High-throughput transcriptome sequencing was used to analyze changes in gene transcription levels in liver tissue. The expressions of factors related to the ERVs/RLRs/IFN-I signaling pathway in liver tissue were detected using qRT-PCR, Western blotting and ELISA. A HF model was established in Mavs-/- mice and intervened with HQ-DS to verify the mechanism of HQ-DS’s anti-HF effect. In vitro experiments were conducted using CCK-8 assay to evaluate the effect of HQ-DS on the activity of iBMDM cells stimulated by lipopolysaccharides (LPS) and nigericin. Immunofluorescence detection of dsRNA expression was performed, qRT-PCR and Western blotting were used to further verify the inhibitory effect of HQ-DS on the activation of ERVs. Results Compared with control group, the body weight of mice in model group was increased slowly, with vacuolar degeneration and inflammatory cell infiltration in liver tissue, liver function related indicators in serum were significantly increased (P < 0.001), and the expressions of factors related to the ERVs/RLRs/IFN-I signaling pathway in liver tissue were significantly increased (P < 0.001). Compared with model group, HQ-DS and silymarin intervention significantly improved the slow growth of body weight in mice (P < 0.01, 0.001), significantly reduced the degree of vacuolar degeneration and inflammatory infiltration in liver tissue, significantly reduced liver function related indicators in serum (P < 0.01, 0.001), effectively alleviated the process of HF, and significantly reduced the expressions of factors related to the ERVs/RLRs/IFN-I signaling pathway in liver tissue (P < 0.05, 0.01, 0.001). Subsequent verification of the underlying mechanisms revealed that in Mavs-/- mice, the elevation of pro-inflammatory factors induced by CCl4 was markedly suppressed (P < 0.001), the mRNA expression levels of factors associated with the ERVs/RLRs/IFN-I signaling pathway were significantly downregulated (P < 0.001). However, following the administration of HQ-DS, there was no significant change in the mRNA expression levels of inflammatory factors and factors related to the ERVs/RLRs/IFN-I pathway. In cell experiments, compared with model group, HQ-DS significantly increased iBMDM cell viability (P < 0.001), reduced dsRNA accumulation, and downregulated the expressions of core genes in ERVs and IFN-I pathways (P < 0.05, 0.01, 0.001), while inhibited the expressions of key proteins [phosphorylated TANK binding kinase 1 (p-TBK1), phosphorylated interferon regulatory factor 3 (p-IRF3)] in RLRs pathway (P < 0.05, 0.01, 0.001). Conclusion HQ-DS alleviates inflammatory injury and ameliorates the progression of HF in mice by inhibiting ERVs/RLRs/IFN-I signaling pathway., authors=ZHOU Feng1,2, LI Zewei1,2, HUANG Yi1,2, SONG Hao1,2, YANG Xuebin2,3, TAN Yang1,2, PEI Gang1,2, KUANG Ming1,2, authorsList=ZHOU Feng, LI Zewei, HUANG Yi, SONG Hao, YANG Xuebin, TAN Yang, PEI Gang, KUANG Ming, authorCompany=1 School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China;
2 Key Laboratory of Modern Research of Traditional Chinese Medicine, Education Department of Hunan Province, Changsha 410208, China;
3 College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322631265342304319, articleId=1322631264893513790, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=黄芪-丹参药对通过抑制ERVs/RLRs/IFN-I信号通路缓解肝纤维化的机制, columnId=1322631229128691961, journalTitle=中草药, columnName=中药防治器官纤维化研究, runingTitle=null, highlight=null, articleAbstract=目的 基于调控内源性逆转录病毒(endogenous retroviruses,ERVs)/维甲酸诱导基因I样受体(retinoic acid-inducible gene I-like receptors,RLRs)/I型干扰素(type I interferon,IFN-I)信号通路,探讨黄芪-丹参药对(Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair,HQ-DS)治疗肝纤维化(hepatic fibrosis,HF)的作用机制。方法 通过超高效液相色谱-串联质谱(ultra-performance liquid chromatography-tandem mass spectrometry,UPLC-MS/MS)对HQ-DS提取物以及含药血清进行成分分析与鉴定。将48只雄性C57BL/6J小鼠随机分为对照组、模型组及HQ-DS低、中、高剂量(4.55、9.10、18.20 g/kg)组和水飞蓟素(100 mg/kg)组,每组8只。采用四氯化碳(carbon tetrachloride,CCl₄)建立HF小鼠模型,给予药物干预后,检测血清中肝功能相关指标;通过苏木素-伊红(hematoxylin-eosin,HE)染色、Masson和天狼星红染色观察肝组织病理变化;流式细胞术检测肝组织巨噬细胞浸润情况;Western blotting检测肝组织纤维化相关蛋白表达;采用高通量转录组测序分析肝组织基因转录水平变化;通过qRT-PCR、Western blotting和ELISA检测肝组织ERVs/RLRs/IFN-I信号通路相关因子表达。通过Mavs⁻/⁻小鼠建立HF模型后给予HQ-DS进行干预,验证HQ-DS抗HF的作用机制。体外实验采用CCK-8实验评估HQ-DS对脂多糖(lipopolysaccharide,LPS)、尼日利亚菌素(Nigericin)刺激iBMDM细胞活力的影响,免疫荧光检测dsRNA表达,qRT-PCR和Western blotting进一步验证HQ-DS对ERVs激活的抑制作用。结果 与对照组比较,模型组小鼠体质量增加缓慢,肝组织出现空泡样变性以及炎症细胞浸润,血清中肝功能相关指标显著升高(P<0.001),肝组织中ERVs/RLRs/IFN-I信号通路相关因子表达显著升高(P<0.001);与模型组比较,HQ-DS和水飞蓟素干预后小鼠体质量增长缓慢显著改善(P<0.01、0.001),肝组织空泡变性及炎症浸润程度明显减轻,血清中肝功能相关指标显著降低(P<0.01、0.001),HF进程得到有效缓解,肝组织ERVs/RLRs/IFN-I信号通路相关因子表达显著降低(P<0.05、0.01、0.001)。进一步的机制验证显示,在Mavs⁻/⁻小鼠中,CCl₄诱导的促炎因子升高被显著抑制(P<0.001),且ERVs/RLRs/IFN-I通路相关因子的mRNA表达水平亦被显著下调(P<0.001);给予HQ-DS后炎症因子和ERVs/RLRs/IFN-I通路相关因子的mRNA表达水平均无显著改变。细胞实验中,与模型组比较,HQ-DS显著提高iBMDM细胞活力(P<0.001),减少dsRNA积累,并下调ERVs及IFN-I通路核心基因的表达(P<0.05、0.01、0.001),同时抑制RLRs通路关键蛋白磷酸化TANK结合激酶1(phosphorylated TANK-binding kinase 1,p-TBK1)、磷酸化干扰素调节因子3(phosphorylated interferon regulatory factor 3,p-IRF3)的表达(P<0.05、0.01、0.001)。结论 HQ-DS通过抑制ERVs/RLRs/IFN-I信号通路,减轻肝组织炎症损伤,缓解小鼠HF进程。, authors=周峰1,2, 李泽威1,2, 黄仪1,2, 宋浩1,2, 杨学斌2,3, 谭洋1,2, 裴刚1,2, 邝鸣1,2, authorsList=周峰, 李泽威, 黄仪, 宋浩, 杨学斌, 谭洋, 裴刚, 邝鸣, authorCompany=1 湖南中医药大学药学院, 湖南 长沙 410208;
2 湖南省高等普通学校中药现代化研究重点实验室, 湖南 长沙 410208;
3 湖南中医药大学中医药科学院, 湖南 长沙 410208, correspAuthors=裴刚, authorNote=周峰: 周峰,男,讲师,从事中药物质基础及作用机制研究。E-mail:004871@hnucm.edu.cn, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=ImO9zi7HsMr+mYrKk9/oeA==, pdfFileSize=1223487, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=国家自然科学基金青年项目 (82505414); 湖南省自然科学基金青年科学基金项目 (2026JJ40093); 中药粉体与创新药物省部共建国家重点实验室培育基地开放基金 (25PTKF1005,24PTKF1005))}, authors=null, keywords=[Keyword(id=1322634649520689803, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=CN, orderNo=1, keyword=肝纤维化), Keyword(id=1322634649579410060, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=CN, orderNo=2, keyword=黄芪-丹参药对), Keyword(id=1322634649646518925, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=CN, orderNo=3, keyword=内源性逆转录病毒), Keyword(id=1322634649717822094, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=CN, orderNo=4, keyword=RLRs信号通路), Keyword(id=1322634649831068303, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=CN, orderNo=5, keyword=I型干扰素), Keyword(id=1322634649885594256, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=CN, orderNo=6, keyword=巨噬细胞), Keyword(id=1322634650086920849, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=EN, orderNo=1, keyword=hepatic fibrosis), Keyword(id=1322634650166612626, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=EN, orderNo=2, keyword=Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair), Keyword(id=1322634650233721491, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=EN, orderNo=3, keyword=endogenous retrovirus), Keyword(id=1322634650325996180, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=EN, orderNo=4, keyword=RLRs signaling pathway), Keyword(id=1322634650397299349, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=EN, orderNo=5, keyword=type I interferons), Keyword(id=1322634650493768342, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1322631264893513790, language=EN, orderNo=6, keyword=macrophage)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1302309778002903112, delFlag=0, nameCn=中草药, nameEn=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, issn=0253-2670, eissn=null, cn=12-1108/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=cGpSKCP11AF8PAOcTXYWfg==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Traditional and Herbal Drugs, journalRemark=null, publicationField=null, createdTime=1788424446827, updatedTime=1788949289390, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=cGpSKCP11AF8PAOcTXYWfg==, picEn=Xw//kxUC3ON4eHxev0QLhQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1304511127375863983, language=CN, name=中草药, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289411, updatedTime=1788949289411, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304511127442972848, language=EN, name=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289427, updatedTime=1788949289427, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1302319053441957962, websiteList=[Website(id=1302319176408912052, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/CN, language=CN, createTime=1788426687576, createBy=18614031015, updateTime=1788427346252, updateBy=18614031015, name=中草药-中文, tplId=1146099689490845704, title=中草药, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322043651904087, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=articleTextType, value=kx, createTime=1788427371180, updateTime=1788427371180, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043593183828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=banner, value=null, createTime=1788427371166, updateTime=1788427371166, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043672875610, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=grayFlag, value=0, createTime=1788427371185, updateTime=1788427371185, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043584795219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427371164, updateTime=1788427371164, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043689652828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=minRunFlag, value=0, createTime=1788427371189, updateTime=1788427371189, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043643515478, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic, createTime=1788427371178, updateTime=1788427371178, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043681264219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=silenceFlag, value=0, createTime=1788427371187, updateTime=1788427371187, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043601572437, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1788427371168, updateTime=1788427371168, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043660292696, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeColor, value=null, createTime=1788427371182, updateTime=1788427371182, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043668681305, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeStyle, value=null, createTime=1788427371184, updateTime=1788427371184, creator=18614031015, updator=18614031015)]), Website(id=1302319176715096246, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/EN, language=EN, createTime=1788426687649, createBy=18614031015, updateTime=1788427341161, updateBy=18614031015, name=中草药-英文, tplId=1146101810881728533, title=Chinese Traditional and Herbal Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322015206134340, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=articleTextType, value=kx, createTime=1788427364398, updateTime=1788427364398, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015185162817, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=banner, value=null, createTime=1788427364393, updateTime=1788427364393, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015227105863, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=grayFlag, value=0, createTime=1788427364403, updateTime=1788427364403, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015176774208, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427364391, updateTime=1788427364391, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015239688777, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=minRunFlag, value=0, createTime=1788427364406, updateTime=1788427364406, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015201940035, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic, createTime=1788427364397, updateTime=1788427364397, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015235494472, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=silenceFlag, value=0, createTime=1788427364405, updateTime=1788427364405, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015193551426, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1788427364395, updateTime=1788427364395, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015214522949, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeColor, value=null, createTime=1788427364400, updateTime=1788427364400, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015218717254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeStyle, value=null, createTime=1788427364401, updateTime=1788427364401, creator=18614031015, updator=18614031015)])], journalTitle=中草药, weixinUrl=null, journalUrl=https://www.tiprpress.com/zcy, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Traditional and Herbal Drugs, journalPhotoCn=cGpSKCP11AF8PAOcTXYWfg==, journalPhotoEn=Xw//kxUC3ON4eHxev0QLhQ==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.18.008, detailUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2026.18.008, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/PDF/10.7501/j.issn.0253-2670.2026.18.008, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/PDF/10.7501/j.issn.0253-2670.2026.18.008, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1790524800000, fullTextJson=null, articleText=null, reference=Taru V, Szabo G, Mehal W, et al. Inflammasomes in chronic liver disease:Hepatic injury, fibrosis progression and systemic inflammation[J]. J Hepatol, 2024, 81(5):895-910.
Li Y J, Li F H, Ding M N, et al. Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYCH19 pathway[J]. Chin Herb Med, 2024, 16(1):82-93.
Luo X F, He Y H, Jiang Z, et al. Global burden of liver cirrhosis:Trends from 1990-2021 and projections to2060[J]. J Health Popul Nutr, 2025, 44(1):370.
Widowati W, Sabrina A H N, Sutendi A F, et al. Immune system and hepatic stellate cells’ crosstalk in liver fibrosis:Pathways and therapeutic potential[J]. J Immunol Res,2026, 2026:2656395.
Taranto D, Kloosterman D J, Akkari L. Macrophages and T cells in metabolic disorder-associated cancers[J]. Nat Rev Cancer, 2024, 24(11):744-767.
Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis[J]. Nat Rev Gastroenterol Hepatol, 2023,20(10):633-646.
Wang W Z, Li S W, Liu Y J, et al. Macrophage heterogeneity in liver fibrosis[J]. Front Immunol, 2025,16:1639455.
Wang Q Y, Yu Y, Zhuang J, et al. Demystifying the cGASSTING pathway:Precision regulation in the tumor immune microenvironment[J]. Mol Cancer, 2025, 24(1):178.
Villablanca E J, Selin K, Hedin C R H. Mechanisms of mucosal healing:Treating inflammatory bowel disease without immunosuppression?[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(8):493-507.
McElrath C, Espinosa V, Lin J D, et al. Critical role of interferons in gastrointestinal injury repair[J]. Nat Commun, 2021, 12(1):2624.
Chen R C, Zou J, Chen J W, et al. Pattern recognition receptors:Function, regulation and therapeutic potential[J]. Signal Transduct Target Ther, 2025, 10(1):216.
Zheng J, Shi W J, Yang Z Q, et al. RIG-I-like receptors:Molecular mechanism of activation and signaling[J]. Adv Immunol, 2023, 158:1-74.
Di Giorgio E, Xodo L E. Endogenous retroviruses(ERVs):Does RLR(RIG-I-like receptors)-MAVS pathway directly control senescence and aging as a consequence of ERV derepression?[J]. Front Immunol, 2022, 13:917998.
Park S J, Garcia Diaz J, Comlekoglu T, et al. Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling[J]. Front Immunol,2025, 16:1528382.
中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南(2019年版)[J]. 中国中西医结合杂志, 2019, 39(11):1286-1295.
韦柳婷,高松林,吴凡,等.专利中药复方治疗肝纤维化的用药规律及机制研究[J]. 科学技术与工程, 2024,24(8):3133-3144.
杨济铭,雷雪莉,庞莉,等.基于中医传承计算平台分析中药治疗肝纤维化用药规律[J]. 中西医结合肝病杂志, 2022, 32(11):1012-1015.
黄丹,孙定隆,王敏,等.扶脾柔肝汤治疗肝硬化40例临床报道[J]. 贵阳中医学院学报, 2015(5):51-53.
Hu Y T, Kuang M, Song H, et al. Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization[J]. Eur J Pharmacol, 2025, 995:177353.
胡兴兰,杨莹莹,黄盼玲,等.荔枝核总黄酮通过改善肠道菌群结构减轻四氯化碳诱发的肝纤维化[J]. 中草药, 2025, 56(1):145-153.
van Huizen M, Gack M U. The RIG-I-like receptor family of immune proteins[J]. Mol Cell, 2025, 85(20):3793-3806.
Yuan Y, Li J X, Rao D A, et al. ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation[J]. Gut, 2026, 75(6):1186-1200.
Wu Y, Huang S, Sha Q, et al. Emerging and re-emerging viruses as triggers of human endogenous retrovirus activation:Implications for aging and age-related pathologies[J]. Mol Aspects Med, 2025, 106:101422.
Mikhalkevich N, O’Carroll I P, Tkavc R, et al. Response of human macrophages to gamma radiation is mediated via expression of endogenous retroviruses[J]. PLoS Pathog,2021, 17(2):e1009305.)
收藏切换
黄芪-丹参药对通过抑制ERVs/RLRs/IFN-I信号通路缓解肝纤维化的机制
收藏切换
PDF下载
中草药 | 中药防治器官纤维化研究 2026,57(18): 7162-7177
收起
收藏切换
中草药 |中药防治器官纤维化研究 2026 , 57 (18) : 7162 -7177
黄芪-丹参药对通过抑制ERVs/RLRs/IFN-I信号通路缓解肝纤维化的机制
全屏
周峰1,2, 李泽威1,2, 黄仪1,2, 宋浩1,2, 杨学斌2,3, 谭洋1,2, 裴刚1,2, 邝鸣1,2
作者信息
    1 湖南中医药大学药学院, 湖南 长沙 410208;
    2 湖南省高等普通学校中药现代化研究重点实验室, 湖南 长沙 410208;
    3 湖南中医药大学中医药科学院, 湖南 长沙 410208
通讯作者:
裴刚
作者简介:
周峰: 周峰,男,讲师,从事中药物质基础及作用机制研究。E-mail:004871@hnucm.edu.cn
Mechanism of Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair alleviates hepatic fibrosis through inhibition of ERVs/RLRs/IFN-I signaling pathway
  • ZHOU Feng1,2, LI Zewei1,2, HUANG Yi1,2, SONG Hao1,2, YANG Xuebin2,3, TAN Yang1,2, PEI Gang1,2, KUANG Ming1,2
  • Affiliations
      1 School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China;
      2 Key Laboratory of Modern Research of Traditional Chinese Medicine, Education Department of Hunan Province, Changsha 410208, China;
      3 College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China
    doi: 10.7501/j.issn.0253-2670.2026.18.008
    文章导航
    收藏切换
    目的 基于调控内源性逆转录病毒(endogenous retroviruses,ERVs)/维甲酸诱导基因I样受体(retinoic acid-inducible gene I-like receptors,RLRs)/I型干扰素(type I interferon,IFN-I)信号通路,探讨黄芪-丹参药对(Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair,HQ-DS)治疗肝纤维化(hepatic fibrosis,HF)的作用机制。方法 通过超高效液相色谱-串联质谱(ultra-performance liquid chromatography-tandem mass spectrometry,UPLC-MS/MS)对HQ-DS提取物以及含药血清进行成分分析与鉴定。将48只雄性C57BL/6J小鼠随机分为对照组、模型组及HQ-DS低、中、高剂量(4.55、9.10、18.20 g/kg)组和水飞蓟素(100 mg/kg)组,每组8只。采用四氯化碳(carbon tetrachloride,CCl₄)建立HF小鼠模型,给予药物干预后,检测血清中肝功能相关指标;通过苏木素-伊红(hematoxylin-eosin,HE)染色、Masson和天狼星红染色观察肝组织病理变化;流式细胞术检测肝组织巨噬细胞浸润情况;Western blotting检测肝组织纤维化相关蛋白表达;采用高通量转录组测序分析肝组织基因转录水平变化;通过qRT-PCR、Western blotting和ELISA检测肝组织ERVs/RLRs/IFN-I信号通路相关因子表达。通过Mavs⁻/⁻小鼠建立HF模型后给予HQ-DS进行干预,验证HQ-DS抗HF的作用机制。体外实验采用CCK-8实验评估HQ-DS对脂多糖(lipopolysaccharide,LPS)、尼日利亚菌素(Nigericin)刺激iBMDM细胞活力的影响,免疫荧光检测dsRNA表达,qRT-PCR和Western blotting进一步验证HQ-DS对ERVs激活的抑制作用。结果 与对照组比较,模型组小鼠体质量增加缓慢,肝组织出现空泡样变性以及炎症细胞浸润,血清中肝功能相关指标显著升高(P<0.001),肝组织中ERVs/RLRs/IFN-I信号通路相关因子表达显著升高(P<0.001);与模型组比较,HQ-DS和水飞蓟素干预后小鼠体质量增长缓慢显著改善(P<0.01、0.001),肝组织空泡变性及炎症浸润程度明显减轻,血清中肝功能相关指标显著降低(P<0.01、0.001),HF进程得到有效缓解,肝组织ERVs/RLRs/IFN-I信号通路相关因子表达显著降低(P<0.05、0.01、0.001)。进一步的机制验证显示,在Mavs⁻/⁻小鼠中,CCl₄诱导的促炎因子升高被显著抑制(P<0.001),且ERVs/RLRs/IFN-I通路相关因子的mRNA表达水平亦被显著下调(P<0.001);给予HQ-DS后炎症因子和ERVs/RLRs/IFN-I通路相关因子的mRNA表达水平均无显著改变。细胞实验中,与模型组比较,HQ-DS显著提高iBMDM细胞活力(P<0.001),减少dsRNA积累,并下调ERVs及IFN-I通路核心基因的表达(P<0.05、0.01、0.001),同时抑制RLRs通路关键蛋白磷酸化TANK结合激酶1(phosphorylated TANK-binding kinase 1,p-TBK1)、磷酸化干扰素调节因子3(phosphorylated interferon regulatory factor 3,p-IRF3)的表达(P<0.05、0.01、0.001)。结论 HQ-DS通过抑制ERVs/RLRs/IFN-I信号通路,减轻肝组织炎症损伤,缓解小鼠HF进程。
    肝纤维化  /  黄芪-丹参药对  /  内源性逆转录病毒  /  RLRs信号通路  /  I型干扰素  /  巨噬细胞
    Objective To investigate the mechanism by which Huangqi (Astragali Radix)-Danshen (Salviae Miltiorrhizae Radix et Rhizoma) herb pair (HQ-DS) in treating hepatic fibrosis (HF) via regulating the endogenous retroviruses (ERVs)/retinoic acid-inducible gene I-like receptors (RLRs)/type I interferon (IFN-I) signaling pathway. Methods The components of HQ-DS extract and drug-containing serum were analyzed and identified using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). A total of 48 male C57BL/6J mice were randomly divided into control group, model group, HQ-DS low-, medium-, high-dose (4.55, 9.10, 18.20 g/kg) groups and silymarin (100 mg/kg) group, with eight mice in each group. A mouse model of HF was established using carbon tetrachloride (CCl4), and after drug intervention, liver function related indicators in serum were detected. The pathological changes of liver tissue through hematoxylin eosin (HE) staining, Masson and Sirius red staining were observed. Flow cytometry was used to detect macrophage infiltration in liver tissue. Western blotting was used to detect the expressions of fibrosis related proteins in liver tissue. High-throughput transcriptome sequencing was used to analyze changes in gene transcription levels in liver tissue. The expressions of factors related to the ERVs/RLRs/IFN-I signaling pathway in liver tissue were detected using qRT-PCR, Western blotting and ELISA. A HF model was established in Mavs-/- mice and intervened with HQ-DS to verify the mechanism of HQ-DS’s anti-HF effect. In vitro experiments were conducted using CCK-8 assay to evaluate the effect of HQ-DS on the activity of iBMDM cells stimulated by lipopolysaccharides (LPS) and nigericin. Immunofluorescence detection of dsRNA expression was performed, qRT-PCR and Western blotting were used to further verify the inhibitory effect of HQ-DS on the activation of ERVs. Results Compared with control group, the body weight of mice in model group was increased slowly, with vacuolar degeneration and inflammatory cell infiltration in liver tissue, liver function related indicators in serum were significantly increased (P < 0.001), and the expressions of factors related to the ERVs/RLRs/IFN-I signaling pathway in liver tissue were significantly increased (P < 0.001). Compared with model group, HQ-DS and silymarin intervention significantly improved the slow growth of body weight in mice (P < 0.01, 0.001), significantly reduced the degree of vacuolar degeneration and inflammatory infiltration in liver tissue, significantly reduced liver function related indicators in serum (P < 0.01, 0.001), effectively alleviated the process of HF, and significantly reduced the expressions of factors related to the ERVs/RLRs/IFN-I signaling pathway in liver tissue (P < 0.05, 0.01, 0.001). Subsequent verification of the underlying mechanisms revealed that in Mavs-/- mice, the elevation of pro-inflammatory factors induced by CCl4 was markedly suppressed (P < 0.001), the mRNA expression levels of factors associated with the ERVs/RLRs/IFN-I signaling pathway were significantly downregulated (P < 0.001). However, following the administration of HQ-DS, there was no significant change in the mRNA expression levels of inflammatory factors and factors related to the ERVs/RLRs/IFN-I pathway. In cell experiments, compared with model group, HQ-DS significantly increased iBMDM cell viability (P < 0.001), reduced dsRNA accumulation, and downregulated the expressions of core genes in ERVs and IFN-I pathways (P < 0.05, 0.01, 0.001), while inhibited the expressions of key proteins [phosphorylated TANK binding kinase 1 (p-TBK1), phosphorylated interferon regulatory factor 3 (p-IRF3)] in RLRs pathway (P < 0.05, 0.01, 0.001). Conclusion HQ-DS alleviates inflammatory injury and ameliorates the progression of HF in mice by inhibiting ERVs/RLRs/IFN-I signaling pathway.
    hepatic fibrosis  /  Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair  /  endogenous retrovirus  /  RLRs signaling pathway  /  type I interferons  /  macrophage
    周峰, 李泽威, 黄仪, 宋浩, 杨学斌, 谭洋, 裴刚, 邝鸣. 黄芪-丹参药对通过抑制ERVs/RLRs/IFN-I信号通路缓解肝纤维化的机制. 中草药, 2026 , 57 (18) : 7162 -7177 . DOI: 10.7501/j.issn.0253-2670.2026.18.008
    ZHOU Feng, LI Zewei, HUANG Yi, SONG Hao, YANG Xuebin, TAN Yang, PEI Gang, KUANG Ming. Mechanism of Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma herb pair alleviates hepatic fibrosis through inhibition of ERVs/RLRs/IFN-I signaling pathway[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (18) : 7162 -7177 . DOI: 10.7501/j.issn.0253-2670.2026.18.008

      国家自然科学基金青年项目 (82505414); 湖南省自然科学基金青年科学基金项目 (2026JJ40093); 中药粉体与创新药物省部共建国家重点实验室培育基地开放基金 (25PTKF1005,24PTKF1005)

    参考文献 引证文献
    排序方式:
    Taru V, Szabo G, Mehal W, et al. Inflammasomes in chronic liver disease:Hepatic injury, fibrosis progression and systemic inflammation[J]. J Hepatol, 2024, 81(5):895-910.
    Li Y J, Li F H, Ding M N, et al. Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYCH19 pathway[J]. Chin Herb Med, 2024, 16(1):82-93.
    Luo X F, He Y H, Jiang Z, et al. Global burden of liver cirrhosis:Trends from 1990-2021 and projections to2060[J]. J Health Popul Nutr, 2025, 44(1):370.
    Widowati W, Sabrina A H N, Sutendi A F, et al. Immune system and hepatic stellate cells’ crosstalk in liver fibrosis:Pathways and therapeutic potential[J]. J Immunol Res,2026, 2026:2656395.
    Taranto D, Kloosterman D J, Akkari L. Macrophages and T cells in metabolic disorder-associated cancers[J]. Nat Rev Cancer, 2024, 24(11):744-767.
    Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis[J]. Nat Rev Gastroenterol Hepatol, 2023,20(10):633-646.
    Wang W Z, Li S W, Liu Y J, et al. Macrophage heterogeneity in liver fibrosis[J]. Front Immunol, 2025,16:1639455.
    Wang Q Y, Yu Y, Zhuang J, et al. Demystifying the cGASSTING pathway:Precision regulation in the tumor immune microenvironment[J]. Mol Cancer, 2025, 24(1):178.
    Villablanca E J, Selin K, Hedin C R H. Mechanisms of mucosal healing:Treating inflammatory bowel disease without immunosuppression?[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(8):493-507.
    McElrath C, Espinosa V, Lin J D, et al. Critical role of interferons in gastrointestinal injury repair[J]. Nat Commun, 2021, 12(1):2624.
    Chen R C, Zou J, Chen J W, et al. Pattern recognition receptors:Function, regulation and therapeutic potential[J]. Signal Transduct Target Ther, 2025, 10(1):216.
    Zheng J, Shi W J, Yang Z Q, et al. RIG-I-like receptors:Molecular mechanism of activation and signaling[J]. Adv Immunol, 2023, 158:1-74.
    Di Giorgio E, Xodo L E. Endogenous retroviruses(ERVs):Does RLR(RIG-I-like receptors)-MAVS pathway directly control senescence and aging as a consequence of ERV derepression?[J]. Front Immunol, 2022, 13:917998.
    Park S J, Garcia Diaz J, Comlekoglu T, et al. Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling[J]. Front Immunol,2025, 16:1528382.
    中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南(2019年版)[J]. 中国中西医结合杂志, 2019, 39(11):1286-1295.
    韦柳婷,高松林,吴凡,等.专利中药复方治疗肝纤维化的用药规律及机制研究[J]. 科学技术与工程, 2024,24(8):3133-3144.
    杨济铭,雷雪莉,庞莉,等.基于中医传承计算平台分析中药治疗肝纤维化用药规律[J]. 中西医结合肝病杂志, 2022, 32(11):1012-1015.
    黄丹,孙定隆,王敏,等.扶脾柔肝汤治疗肝硬化40例临床报道[J]. 贵阳中医学院学报, 2015(5):51-53.
    Hu Y T, Kuang M, Song H, et al. Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization[J]. Eur J Pharmacol, 2025, 995:177353.
    胡兴兰,杨莹莹,黄盼玲,等.荔枝核总黄酮通过改善肠道菌群结构减轻四氯化碳诱发的肝纤维化[J]. 中草药, 2025, 56(1):145-153.
    van Huizen M, Gack M U. The RIG-I-like receptor family of immune proteins[J]. Mol Cell, 2025, 85(20):3793-3806.
    Yuan Y, Li J X, Rao D A, et al. ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation[J]. Gut, 2026, 75(6):1186-1200.
    Wu Y, Huang S, Sha Q, et al. Emerging and re-emerging viruses as triggers of human endogenous retrovirus activation:Implications for aging and age-related pathologies[J]. Mol Aspects Med, 2025, 106:101422.
    Mikhalkevich N, O’Carroll I P, Tkavc R, et al. Response of human macrophages to gamma radiation is mediated via expression of endogenous retroviruses[J]. PLoS Pathog,2021, 17(2):e1009305.
    2026年第57卷第18期
    PDF下载
    50
    10
    引用本文
    BibTeX
    文章信息
    doi: 10.7501/j.issn.0253-2670.2026.18.008
    • 接收时间:2026-05-15
    • 首发时间:2026-10-29
    补充材料
    相关文章
    文章信息
    作者
    出版历史
    • 收稿日期:2026-05-15
    基金
    作者信息
    参考文献
    分享链接
    https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.18.008
    分享至
    全文二维码

    扫描看全文

    引用本文
    BibTeX
    本文的引用情况
    2种不同金属材料的力学参数
    科
    Family
    属数
    Number of
    genus
    种数
    Number of
    species
    占总种数比例
    Percentage of
    total species (%)
    属
    Genus
    种数
    Number of
    species
    占总种数比例
    Percentage of total
    species (%)
    鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
    小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
    多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
    红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
    小菇属 Mycena 11 5.26
    光柄菇属 Pluteus 5 2.39
    红菇属 Russula 17 8.13
    栓菌属 Trametes 5 2.39
    关闭全屏